MedTrace Logo

Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache

NCT01791400 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2013-02-15

No results posted yet for this study

Summary

The purpose of this study is to determine which drug makes lower migraine headache

Conditions

  • Migraine Disorders

Interventions

DRUG

metoclopramide, injection,20mg, one time

metoclopramide, intravenous injection,20mg, one time

DRUG

Sumatriptan, injection, 6 mg, one time

Sumatriptan, subcutaneous injection, 6 mg, one time

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    lead OTHER

Principal Investigators

  • babak masoumi, A.Professor · Isfahan, Isfahan, Iran, Islamic Republic of

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791400 on ClinicalTrials.gov